Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner.
about
Epigenetic pathways regulating bone homeostasis: potential targeting for intervention of skeletal disorders.Histone deacetylase inhibition destabilizes the multi-potent state of uncommitted adipose-derived mesenchymal stromal cellsDifferent tenogenic differentiation capacities of different mesenchymal stem cells in the presence of BMP-12.Epigenetic Mechanisms Regulating Mesenchymal Stem Cell Differentiation.Histone deacetylase inhibition promotes osteoblast maturation by altering the histone H4 epigenome and reduces Akt phosphorylation.Bone morphogenetic protein 9 (BMP9) induces effective bone formation from reversibly immortalized multipotent adipose-derived (iMAD) mesenchymal stem cells.KDM5A controls bone morphogenic protein 2-induced osteogenic differentiation of bone mesenchymal stem cells during osteoporosis.Ovarian cancer stem-like cells show induced translineage-differentiation capacity and are suppressed by alkaline phosphatase inhibitor.Realizing the potential of gene-based molecular therapies in bone repair.Histone deacetylase inhibitor sodium butyrate promotes the osteogenic differentiation of rat adipose-derived stem cells.Profiling of human epigenetic regulators using a semi-automated real-time qPCR platform validated by next generation sequencing.Histone deacetylases and their roles in mineralized tissue regenerationHistone Deacetylase Inhibitor Trichostatin a Promotes the Apoptosis of Osteosarcoma Cells through p53 Signaling Pathway Activation.Runt-Related Transcription Factor 2 Induction During Differentiation of Wharton's Jelly Mesenchymal Stem Cells to Osteoblasts Is Regulated by Jumonji AT-Rich Interactive Domain 1B Histone Demethylase.Engineering Lineage Potency and Plasticity of Stem Cells using Epigenetic Molecules
P2860
Q34437672-2609F8C4-969C-43C2-A311-44E1A6D3A56EQ34475885-5148A85B-FC69-4D86-8898-832E7C3AA00EQ35776598-2430DA03-189B-475E-817A-D45C20ADF85CQ36613056-D3783800-E714-4056-9F96-CCB0EB0DF1D8Q37213816-F12E7E24-5E96-41C6-AFA8-E67769A8AC30Q37293132-2B418481-1ECC-41B5-A6DF-E27E64B1BEA1Q37412502-0B506C66-1571-46DB-8BEF-8B7F1B50138EQ37589137-3EABC4CA-8869-454A-A295-5CA18518EB0EQ38095878-2254702E-6399-48AD-B43D-D962249760C5Q38309183-00E4AA72-405A-48DE-9E7C-D27FCB9CE1CCQ38993135-55A8F4A4-9A74-45F6-8E95-8C9534116F77Q41479037-43009F38-4BC2-4DBC-8983-29E32399981EQ42364933-58A66931-A6FA-4986-B43D-446C898ED1F8Q47686323-4949E5D0-A95D-4A07-B28B-FBF3FC283165Q58618195-0B6F6694-5C53-42AF-B322-5D3D2C90D502
P2860
Histone deacetylase inhibitor trichostatin A promotes the osteogenic differentiation of rat adipose-derived stem cells by altering the epigenetic modifications on Runx2 promoter in a BMP signaling-dependent manner.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Histone deacetylase inhibitor ...... MP signaling-dependent manner.
@en
Histone deacetylase inhibitor ...... MP signaling-dependent manner.
@nl
type
label
Histone deacetylase inhibitor ...... MP signaling-dependent manner.
@en
Histone deacetylase inhibitor ...... MP signaling-dependent manner.
@nl
prefLabel
Histone deacetylase inhibitor ...... MP signaling-dependent manner.
@en
Histone deacetylase inhibitor ...... MP signaling-dependent manner.
@nl
P2093
P356
P1476
Histone deacetylase inhibitor ...... MP signaling-dependent manner.
@en
P2093
Chunyan Zhou
Jingxian Zhu
Linghui Dai
Weiping Wang
Xiaoqing Hu
Yingfang Ao
Zhuqing Jia
P304
P356
10.1089/SCD.2012.0105
P577
2012-11-02T00:00:00Z